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Chapter 6
Long-term safety of intracoronary haemodynamic assessment for 






Intracoronary flow and pressure measurements can be used for evaluating intermediate lesions. 
Studies focussing on short- and medium-term results demonstrated it’s safety. Long-term results 
our however not available. 
Objective
 The goal of this study was to assess the long-term safety and clinical implications of decision mak-
ing for intermediate coronary stenosis based on intra-coronary hemodynamic measurements.
Methods and Results
In this prospective study, 61 patients with an intermediate coronary stenosis in the period of 
January 1994 to December 1998 were included. In these patients either coronary flow reserve or 
fractional flow reserve were measured. Death, target vessel revascularisation, myocardial infarc-
tion, unstable angina and cerebrovascular accident were considered as major adverse cardiac 
events. The patients were followed during 5.5 ± 1.8 years for the occurrence of major adverse 
cardiac events (mace). Although patients presented with complaints, only 19.7% experienced a 
mace in the follow-up period.
Conclusion
 Intracoronary measurements of cfr and ffr can be routinely used for justified clinical decision 
making in intermediate coronary stenoses. The low 5-year event rate supports conservative 




Revascularisation through coronary angioplasty is the treatment of choice in the presence of 
symptomatic single- or two-vessel coronary artery disease. However, barotrauma following bal-
loon inflation severely damages the endothelial layer of the vessel. In significant coronary artery 
disease the benefit of restoring adequate flow is superior to a conservative therapeutic strategy, 
however, the treatment of intermediate coronary lesions is yet debatable. To investigate whether 
an intermediate stenosis causes ischemia, myocardial scintigraphy has been widely used. In addi-
tion, intra-coronary assessment of the hemodynamic significance of such a stenosis is commonly 
used.  For this purpose, coronary flow reserve (cfr) or the fractional flow reserve (ffr) can 
be measured using coronary flow- or pressure wires respectively. These measurements have 
been validated in many different situations, such as in patients with chronic occlusions, 1 prior 
myocardial infarction, 2 multiple stenoses in a single vessel, 3 stented vessels 4 and intermediate 
coronary stenoses. 5-9 It was shown that the presence of a normal cfr or ffr is compatible with 
sufficient myocardial flow and therefore defers a mechanical revascularisation. 10-13 Patients 
with abnormal values are considered to have a hemodynamically significant stenosis and should 
subsequently be revascularised. 
At present, only up to medium-term results (16.6 months) of this strategy are available. 14 
Therefore, the aim of this study was to evaluate the long-term outcome of cfr and ffr measure-
ments in patients with intermediate coronary lesions and to investigate whether any specific 




In this prospective study, patients with an intermediate lesion stenosis were between June 1994 
and December 1998.  Inclusion criteria were an intermediate stenosis, 
complaints of angina and the absence of consensus to perform angioplasty. Patients were not 
included if they participated in any other research project.  
In these patients the cfr or the ffr were measured. If the cfr was higher than 2.0 or the 
ffr >0.75 the lesion was not considered to be of hemodynamic importance. If the cfr was lower 
than 2.0 or the ffr <0.75 the lesion was treated by angioplasty with stent. 
Baseline
Flowire
A 6 or 7 French guiding catheter and a 0.018 inch wire (Flowire; Cardiometrics, Mountain 
View, usa) were introduced in the stenotic part of the coronary artery. This wire has a 12 mhz 
transducer that can be used for Doppler measurements.
 After measuring the baseline flow velocity, a vasodilating agent was administered. This agent 
was either adenosine (12-20 μg as an intracoronary bolus or through an infusion of 140 μg/
kg body weight per minute for 2-4 minutes) or papaverin (12 mg given as an intracoronary 
bolus). 15,16 The flow velocity measurement was repeated, and the ratio between the baseline 
and the hyperemic measurement was calculated. In each lesion this measurement was performed 
twice and the final cfr value was the mean of the two measurements.
Pressure wire
A 0.014 inch pressure guidewire (Radi Medical System, Upsala, Sweden) was used to measure 
the pressure just distal to the stenosis during a period of maximal hyperaemia (using the same 
agents and concentration as in the flowire procedure). The aortic pressure was measured with 
the guiding catheter (6-7 French). The Fractional Flow Reserve (ffr) was calculated as the ratio 
of the coronary pressure distal to the lesion measured by pressure wire, 
to the mean aortic pressure measured by the guiding catheter. 5 The measurement was also 
performed twice and the ffr was taken as the average of both measurements.
Quantitative Coronary Angiography
During the angiography the two orthogonal projections were taken. Quantitative coronary 
angiography (qca) was performed by a previously described and validated automatic contour 
detection technique 17 (cms, Medis Co., Nuenen, the Netherlands and Quantcor qca, pmi-
Siemens, Maastricht, The Netherlands). Off-line qca was performed by an independent analyst, 




The patients were followed for a period of between 4-8 years. Target vessel revascularisation, 
myocardial infarction and cardiac death were considered to be a major adverse cardiac event 
(mace). The follow-up consisted of patient interview. 
Statistical Analysis
All data are reported as number of patients and mean (sd). A p-value of 0.05 or lower was 
considered to be significant. The Chi-square test was used to compare the groups for categorical 
variables. The independent samples t-test (2-sided) was used to compare the groups for continu-
ous data. 
Results
A total of 84 patients were evaluated for an intermediate coronary lesion. Twenty-three patients 
had a cfr lower than 2.0 or a ffr lower than 0.75 and subsequently underwent an angioplasty. 
The study group consisted of the other 61 patients who were considered not to have a hemody-
namic significant coronary lesion based on intracoronary measurements. 
The mean age in the study group was 63.7 (11.0) years and 35 (57.4%) patients were men. 
Baseline characteristics are shown in Table 1. 
cfr was measured in 39 patients and ffr in 24 patients. The extent of coronary artery disease 
and the location and the severity of the intermediate lesion are shown in Table 2.
The mean follow-up was 5.5 (1.8) years and no patients were lost during follow-up. In this 
period no myocardial infarction was reported, 6 patients were hospitalised for a cerebrovascular 
accident and only 4 patients died from cardiovascular complications. Eleven patients returned 
with complaints and had either a ptca (7 patients) or a cabg (4 patients). However, it must be 
mentioned that 2 of the ptca’s were not performed in the same vessel as the initial measurement. 
A total of 19.7% had an event related to the target vessel. (Table 3). 
Interestingly, despite the normal cfr or ffr, all patients with an old myocardial infarction 
experienced an event. Patients with multi-vessel disease (12 patients with 2-vessel disease and 3 
patients with 3-vessel disease) were not found to have a higher incidence of mace than patients 
with single-vessel disease (p=0.40).
During the same inclusion period, 23 patients who were evaluated through intracoronary mea-
surements for moderate stenoses, were judged to have a significant stenosis. In these patients a 
ptca was performed. The baseline characteristics of these patients were not significantly differ-
ent from the patients in this study. The average diameter stenosis was only 8% higher than the 
diameter stenosis of the patients in this study. In this group 6 mace occurred during follow-up 
(26%; v 19.7% in our study group, p=ns)
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Table 1. Baseline Patient Characteristics
Age (yrs) 63.7 (11.0%)
Men 35 (57.4%)




Family History of cad 20 (32.8%)
Obesity 33 (54.1%)
Atherosclerotic Lesions in 1 Vessel 46 (75%)
Atherosclerotic Lesions in 2 Vessels 12 (20%)
Atherosclerotic Lesions in 3 Vessels 3 (5%)
Previous mi 4 (6.6%)
Previous mi in related area 3 (4.9%)
Previous ptca in related area 10 (16%)
Previous cabg in related area 2 (3%)
 
Table 2. Lesion characteristics
Flowire measurements 39 (63.9%)
cfr 2.68 (0.68)
range 2.0-5.0
Pressure wire measurements 24 (39.3%)
ffr 0.92 (0.08)
range 0.75-1.00
qca - analysis 60 (98.3%)
Diameter stenosis 28.7(10.8)
range 5.0-54.0
Diameter stenosis > 50% 2 (3.3%)
Coronary artery involved
Left Anterior Descending (lad) 47 (77.0%)
Left Circumflex (lcx) 6 (9.9%)
Right Coronary Artery (rca) 8 (13.1%)
Legend Table 1 
Data is presented as mean (sd) for age, and as number of patients (percantage) in all other variables. cabg = Coro-
nary Artery Bypass Grafting. cad = Coronary Artery Disease. dm = Diabetes Mellitus. mi = Myocardial Infarction. 
ptca = Percutaneous Transluminal Coronary Angioplasty. Obesity was defined as a Body Mass Index of > 25.
Legend Table 2 
Data is presented as mean  (sd) or as number of cases (%). cfr = Coronary Flow Reserve. ffr = Fractional Flow 
Reserve. qca = Quantitative Coronary Angiography
section 2
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Table 3. Events at follow-up
Average follow-up (yrs) 5.5 (1.8)
Patients with mace (%) 12 (19.7%)
Myocardial infarction 0 (0%)
ptca 4 (6.6%)
cabg 5 (8.2%)
cva - tia 6 (9.8%)
Death 4 (6.6%)
Discussion
These results of this report confirm that the evaluation of lesion severity based on hemody-
namic measurements can be routinely performed in daily clinical practice. Especially lesions that 
angiographically appear not to be significant are proposed for such intracoronary diagnostic 
procedure. Although having hemodynamic variables that suggest an adequate coronary flow, 
15% of the patients developed a related mace during a follow-up period of 5 years. Interestingly, 
patients with more than one sclerotic narrowing (12 patients with 2-vessel disease and 3 patients 
with 3-vessel disease) had a similar clinical follow-up as patients with one lesion.
In previous studies intracoronary hemodynamic measurements have been used for deferral of 
angioplasty. In those studies patients had initially been accepted for angioplasty based on a 
coronary angiogram. After intracoronary measurements the decision was made whether to 
perform or to defer angioplasty. The angiographic stenosis in these groups of patients were 
approximately 50% by visual examination, 5  47% 12  and 48% 13 based on qca. In addition, 
clinical decision making for treatment of intermediate lesions based on cfr measurements was 
proven to be superior to myocardial scintigraphy. 11 Our study group was selected based on 
the moderate severity of the stenosis (mean diameter stenosis 29%). The lower event rates in 
this study compared to previous studies (mean diameter stenosis 47%) may be related to this 
difference. Although it is known that lesion progression or coronary events occur especially in 
vessels with a non-significant stenosis. 18,19  
The most interesting result in this study is the low event rate. When focussing on hard events 
(myocardial infarction and death), only 6.6% of the patients experienced an event in 5.5 years. 
This is comparable to the event rate in the placebo arm of large primary prevention trials with 
statin therapy. 20,21 Albeit it seems unlikely that the patients in our group experience fewer 
Legend Table 3 
Data is presented as mean (sd) or as number of patients (%). cabg = Coronary Artery Bypass Grafting. cva = 




events than subjects in a healthy population, the combination of optimal non-invasive therapy 
and regular check-ups seems to be a plausible explanation for this difference.
In our study, all seven patients with a previous mi experienced a mace, despite the normal flow 
reserve at baseline. The value of cfr and ffr measurements in patients with a prior myocardial 
infarction has been investigated previously. 22,23 Both studies were conducted in patients with 
a recent mi and the main objective was the validation of the intra-coronary measurements in 
comparison to other diagnostic tools for the detection of myocardial ischemia. In contrast to 
these studies, our study evaluated the long-term clinical outcome after ffr as well as cfr mea-
surements. Although our group contained only seven patients with an old mi, they accounted 
for almost half of the events found in all patients. A previous mi could also be related to an 
adverse event that is not necessarily based on ischemia from the infarct related artery, such as 
heart failure or arrhythmia. Nevertheless, the results of this study may implicate that a prior 
mi could influence the long-term outcome after a cfr or ffr measurements. Although other 
studies do not support this hypothesis, further investigation on this subject might be warranted 
to evaluate whether patients with an old mi should be deferred for angioplasty based on cfr 
and ffr measurements.
In our study group both pressure wire-, and flowire measurements were included, as both 
techniques are standardly used to assess the functional severity of a single coronary stenosis 
and both types of measurements are performed during maximum myocardial hyperaemia. ffr 
is considered to be a measurement purely for the hemodynamic importance of the epicardial 
lesion, whereas cfr also accounts for changes in microvascular resistance. For the follow-up, 
both techniques were combined. ffr and cfr do not represent exactly the same hemodynamic 
phenomenon. However, when considering the present findings, which show no significant 
differences between the two groups, neither for the baseline characteristics nor for the outcome, 
this may suggest that the combination of both groups is valid.
 
Study Limitations
This observational study was performed using cfr/ffr measurements in daily clinical practice. 
Patients were selected based on their typical anginal complaints and an intermediate stenosis, 
which was suspected to be of hemodynamic importance. Such patients are of importance, because 
a treatment decision cannot be based on angiography alone. Due to the observational character 
of the study, no control group was present. In addition, the number of patients is low, as is the 
number of events. This makes it difficult to identify evidence-based predictive variables that 
could influence the long-term outcome. Furthermore, no autopsies were performed, which make 
it difficult to relate cardiac deaths to the target lesions. Nevertheless, this study does reflect daily 
clinical practice and the results can therefore be considered as a practical tool for cardiologists 




Intracoronary measurements (cfr and ffr) can be routinely used in clinical decision making 
for an adequate treatment strategy of intermediate coronary stenosis. A conservative treatment 
strategy based on hemodynamic assessments is safe when cut-off values are implemented. 
The aforementioned strategy indicates that patients deferred for angioplasty have a comparable 
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